Changsha Third Hospital
Changsha Third Hospital
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC | Neoplasm, Residual, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Active, not recruiting | Not stated | 2026-08-31 | NCT05198154 | |
| Metformin Alleviates Abnormal Glucose Metabolism Induced by Statins in Schizophrenia Patients | Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, Schizophrenia Spectrum and Other Psychotic Disorders, metabolic disease, psychiatric disorder, schizophrenia | Recruiting | Phase 3 | 2026-08-03 | NCT07045142 | |
| Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2024-12-02 | NCT05598528 |